The Latin America, Middle East and Africa Glucose Syrup Market is expected to witness market growth of 6.7% CAGR during the forecast period (2022-2028).
High fructose corn syrup (HFCS) is unnatural and unhealthy because it is mostly made from genetically modified corn. Most likely, whether knowingly or unknowingly, people have consumed high fructose corn syrup at some point in life. It's difficult to avoid this dubious type of sugar, which is present in a variety of regularly consumed meals and beverages, including cereals, ultra-processed foods, baked goods, juices, and sodas.
In the past, farmers received subsidies if they didn't sow any crops or harvest any that had already been harvested. They are now compensated for producing too much, which is why HFCS as well as other corn-based products predominate on grocery store shelves. Many doctors are being persuaded by the maize industry to stop warning their patients about the harmful consequences of HFCS. While this is going on, large corporations like Cadbury and Kraft are coming under fire for calling their products "natural" when they actually contain HFCS.
Africa mainly relies on imports to fulfill its pharmaceutical product needs. Up to 90% of the pharmaceuticals utilized in sub-Saharan Africa's $14 billion pharmaceutical market in 2019 were imported. In the region, there were roughly 375 pharmaceutical manufacturers as of 2019. The majority of the pharmaceuticals that are imported into Africa are from foreign nations. As a result, it is anticipated that more new firms is expected to enter the local pharmaceutical market. The pharmaceutical industry is also a priority sector under IDDA III and is covered by a number of continental frameworks and initiatives, such as Agenda 2063, the Pharmaceutical Manufacturing Plan for Africa (PMPA), and its associated business plan (AIDA).
The Brazil market dominated the LAMEA Glucose Syrup Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $97.8 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 5.7% during (2022 - 2028).
Based on Grade, the market is segmented into Beverages, Food and Pharma & Others. Based on Application, the market is segmented into Wine, Sweetening Agent and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Egypt, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. August Oetker KG, Archer Daniels Midland Company, Ingredion, Incorporated, AGRANA Beteiligungs-AG, Tate & Lyle PLC, BENEO GmbH (Südzucker AG), Cargill Corporation, Grain Processing Corporation (Kent Corporation), Royal Avebe U.A., and Roquette Freres SA.
High fructose corn syrup (HFCS) is unnatural and unhealthy because it is mostly made from genetically modified corn. Most likely, whether knowingly or unknowingly, people have consumed high fructose corn syrup at some point in life. It's difficult to avoid this dubious type of sugar, which is present in a variety of regularly consumed meals and beverages, including cereals, ultra-processed foods, baked goods, juices, and sodas.
In the past, farmers received subsidies if they didn't sow any crops or harvest any that had already been harvested. They are now compensated for producing too much, which is why HFCS as well as other corn-based products predominate on grocery store shelves. Many doctors are being persuaded by the maize industry to stop warning their patients about the harmful consequences of HFCS. While this is going on, large corporations like Cadbury and Kraft are coming under fire for calling their products "natural" when they actually contain HFCS.
Africa mainly relies on imports to fulfill its pharmaceutical product needs. Up to 90% of the pharmaceuticals utilized in sub-Saharan Africa's $14 billion pharmaceutical market in 2019 were imported. In the region, there were roughly 375 pharmaceutical manufacturers as of 2019. The majority of the pharmaceuticals that are imported into Africa are from foreign nations. As a result, it is anticipated that more new firms is expected to enter the local pharmaceutical market. The pharmaceutical industry is also a priority sector under IDDA III and is covered by a number of continental frameworks and initiatives, such as Agenda 2063, the Pharmaceutical Manufacturing Plan for Africa (PMPA), and its associated business plan (AIDA).
The Brazil market dominated the LAMEA Glucose Syrup Market by Country in 2021, and is expected to continue to be a dominant market till 2028; thereby, achieving a market value of $97.8 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022 - 2028). Additionally, The UAE market is expected to display a CAGR of 5.7% during (2022 - 2028).
Based on Grade, the market is segmented into Beverages, Food and Pharma & Others. Based on Application, the market is segmented into Wine, Sweetening Agent and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Egypt, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Dr. August Oetker KG, Archer Daniels Midland Company, Ingredion, Incorporated, AGRANA Beteiligungs-AG, Tate & Lyle PLC, BENEO GmbH (Südzucker AG), Cargill Corporation, Grain Processing Corporation (Kent Corporation), Royal Avebe U.A., and Roquette Freres SA.
Scope of the Study
Market Segments Covered in the Report:
By Grade
- Beverages
- Food
- Pharma & Others
By Application
- Wine
- Sweetening Agent
- Others
By Country
- Brazil
- Argentina
- UAE
- Egypt
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Dr. August Oetker KG
- Archer Daniels Midland Company
- Ingredion, Incorporated
- AGRANA Beteiligungs-AG
- Tate & Lyle PLC
- BENEO GmbH (Südzucker AG)
- Cargill Corporation
- Grain Processing Corporation (Kent Corporation)
- Royal Avebe U.A.
- Roquette Freres SA
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 4. LAMEA Glucose Syrup Market by Grade
Chapter 5. LAMEA Glucose Syrup Market by Application
Chapter 6. LAMEA Glucose Syrup Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Dr. August Oetker KG
- Archer Daniels Midland Company
- Ingredion, Incorporated
- AGRANA Beteiligungs-AG
- Tate & Lyle PLC
- BENEO GmbH (Südzucker AG)
- Cargill Corporation
- Grain Processing Corporation (Kent Corporation)
- Royal Avebe U.A.
- Roquette Freres SA
Methodology
LOADING...